Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zeo ScientifiX, Inc.ZEOX · Entity 8005 | Director | May 08, 2025 | May 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zeo ScientifiX, Inc.
Report date May 08, 2025 · Filed May 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.86 · Expires 2030-05-08 | Direct | 5,000 |
Reported balance
After 2025-05-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-05-08 · Grant · Acquired 5,000 · Balance 5,000 F1: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. |
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $2.86 · Expires 2030-05-08 | Direct | 5,000 |
Reported balance
After 2025-05-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-05-08 · Grant · Acquired 5,000 · Balance 5,000 F2: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date.
F2: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2025 Filed May 12, 2025 20:05 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001829126-25-003572 · ownership.xml · derivative · entry 2 Singh Gurvinder Pal · CIK 0001944625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-05-08 F2 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. F2 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,000 shares as of the grant date and will vest as to the remaining 3,000 shares on September 23, 2025. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:05 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.86 | $0.00 |
DisclosureSEC source: 0001829126-25-003572 · ownership.xml · derivative · entry 1 Singh Gurvinder Pal · CIK 0001944625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2030-05-08 F1 · kind: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. F1 · derivative.exercise_date: Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vested in full as of the grant date. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:11 UTC | Zeo ScientifiX, Inc. ZEOX · Entity 8005 | GrantStock Options · Derivative | 5,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001829126-24-002160 · ownership.xml · derivative · entry 1 Singh Gurvinder Pal · CIK 0001944625 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-04-01 F1 · kind: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. F1 · derivative.exercise_date: Represents the grant of stock options under the 2021 Plan. The options vested as to 2,500 shares as of the grant date and will vest as to the remaining 2,500 shares on September 23, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.